Decreased mRNA expression of GATA1 and GATA2 is associated with tumor aggressiveness and poor outcome in clear cell renal cell carcinoma
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Decreased mRNA expression of GATA1 and GATA2 is associated with tumor aggressiveness and poor outcome in clear cell renal cell carcinoma
Authors
Keywords
<em class=EmphasisTypeItalic >GATA1</em>, <em class=EmphasisTypeItalic >GATA2</em>, Renal cell carcinoma, mRNA expression, Prognosis, Survival
Journal
Targeted Oncology
Volume 10, Issue 2, Pages 267-275
Publisher
Springer Nature
Online
2014-09-18
DOI
10.1007/s11523-014-0335-8
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Decreased GATA5 mRNA expression associates with CpG island methylation and shortened recurrence-free survival in clear cell renal cell carcinoma
- (2014) Inga Peters et al. BMC CANCER
- Neurofilament Heavy polypeptideCpG island methylation associates with prognosis of renal cell carcinoma and prediction of antivascular endothelial growth factor therapy response
- (2014) Natalia Dubrowinskaja et al. Cancer Medicine
- Hsa-mir-124-3 CpG island methylation is associated with advanced tumours and disease recurrence of patients with clear cell renal cell carcinoma
- (2013) K Gebauer et al. BRITISH JOURNAL OF CANCER
- External validation and comparison with other models of the International Metastatic Renal-Cell Carcinoma Database Consortium prognostic model: a population-based study
- (2013) Daniel YC Heng et al. LANCET ONCOLOGY
- Expression and prognostic significance of GATA-binding protein 2 in colorectal cancer
- (2013) Lei Chen et al. MEDICAL ONCOLOGY
- Differential Expression of Prognostic Proteomic Markers in Primary Tumour, Venous Tumour Thrombus and Metastatic Renal Cell Cancer Tissue and Correlation with Patient Outcome
- (2013) Alexander Laird et al. PLoS One
- Global cancer statistics
- (2011) Ahmedin Jemal et al. CA-A CANCER JOURNAL FOR CLINICIANS
- The role of the GATA2 transcription factor in normal and malignant hematopoiesis
- (2011) Carmen Vicente et al. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
- GATA2 negatively regulates PTEN by preventing nuclear translocation of androgen receptor and by androgen-independent suppression of PTEN transcription in breast cancer
- (2011) Yu Wang et al. HUMAN MOLECULAR GENETICS
- Single nucleotide polymorphism associations with response and toxic effects in patients with advanced renal-cell carcinoma treated with first-line sunitinib: a multicentre, observational, prospective study
- (2011) Jesus Garcia-Donas et al. LANCET ONCOLOGY
- Fibronectin 1 mRNA expression correlates with advanced disease in renal cancer
- (2010) Sandra Waalkes et al. BMC CANCER
- The transcription factor GATA-1 is overexpressed in breast carcinomas and contributes to survivin upregulation via a promoter polymorphism
- (2010) R Boidot et al. ONCOGENE
- GATA-1 associates with and inhibits p53
- (2009) C. D. Trainor et al. BLOOD
- GATA factors in human neuroblastoma: distinctive expression patterns in clinical subtypes
- (2009) V Hoene et al. BRITISH JOURNAL OF CANCER
- A role for GATA-2 in transition to an aggressive phenotype in prostate cancer through modulation of key androgen-regulated genes
- (2009) M Böhm et al. ONCOGENE
- Analyzing real-time PCR data by the comparative CT method
- (2008) Thomas D Schmittgen et al. Nature Protocols
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started